SMS Pharmaceuticals Ltd (SMSPHARMA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 517655, "name": "SMS Pharma.", "stock_name": "SMS Pharma.", "full_name": "SMS Pharmaceuticals Ltd", "name_url": "stocks-analysis/sms-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "380.00", "chg": -1.2, "chgp": "-0.31%", "dir": -1, "prev_price": "381.20", "mcapval": "3,556.00 Cr", "mcap": "Small Cap", "scripcode": 532815, "symbol": "SMSPHARMA", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE812G01025", "curr_date": "May 25", "curr_time": "", "bse_nse_vol": "9.19 lacs", "exc_status": "Active", "traded_date": "May 25, 2026", "traded_date_str": "2026 05 25", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sms-pharma-517655-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "SMS Pharmaceuticals Ltd Sees Mixed Technical Signals Amid Price Momentum Shift", "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-ltd-sees-mixed-technical-signals-amid-price-momentum-shift-4009874", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SMSPharmaceutic_technicaldot_4009874.png", "date": "2026-05-25 08:01:21", "description": "SMS Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish trend, despite a sharp 10.54% decline in its share price on 25 May 2026. This article analyses the recent technical indicator signals, price action, and relative performance against the Sensex to provide a comprehensive view of the stock’s current market positioning." }, { "title": "SMS Pharmaceuticals Ltd Valuation Shifts Signal Changing Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-ltd-valuation-shifts-signal-changing-price-attractiveness-4009783", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SMSPharmaceutic_valuationdot_4009783.png", "date": "2026-05-25 08:00:31", "description": "SMS Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a very expensive to an expensive rating, reflecting a recalibration of price attractiveness in the Pharmaceuticals & Biotechnology sector. Despite a recent sharp decline in share price, the company’s fundamentals and relative valuation metrics suggest a nuanced investment case amid broader market and sector trends." }, { "title": "Are SMS Pharmaceuticals Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-sms-pharmaceuticals-ltd-latest-results-good-or-bad-4008898", "imagepath": "", "date": "2026-05-23 19:18:53", "description": "SMS Pharmaceuticals Ltd reported its financial results for Q4 FY26, showcasing a mixed performance. The company achieved net sales of ₹237.95 crores, reflecting a sequential growth of 13.07% from ₹210.45 crores in the previous quarter, although this represents a decline of 4.13% compared to ₹248.20 crores in Q4 FY25. The consolidated net profit for the quarter surged to ₹32.71 crores, indicating a significant quarter-on-quarter increase of 39.37% from ₹23.47 crores, and a year-on-year growth of 60.97%.\n\nHowever, the operating margin experienced a contraction, falling to 16.77% from 20.74% in the previous quarter, marking the weakest performance in three quarters. This decline in margins is attributed to a notable 40% increase in employee costs, which rose to ₹29.47 crores from ₹21.05 crores in Q3 FY26. The profit after tax margin also compressed to 8.81% from 11.02% in the previous quarter.\n\nFor the full fi..." }, { "title": "SMS Pharmaceuticals Ltd Falls 4.75%: 4 Key Factors Driving the Week’s Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-ltd-falls-475-4-key-factors-driving-the-weeks-volatility-4008748", "imagepath": "", "date": "2026-05-23 17:06:16", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>18 May:</strong> Stock opens at Rs.397.65, down 0.64% amid cautious sentiment</p>\n <p><strong>19 May:</strong> Technical momentum shifts to mildly bullish; price rises 3.06% to Rs.409.80</p>\n <p><strong>20 May:</strong> Bullish technical signals strengthen; stock gains 3.43% to Rs.423.85</p>\n <p><strong>22 May:</strong> Sharp intraday reversal; stock closes down 10.54% at Rs.381.20</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.397.65</div></div>\n <div class=\"stat-item\"><div cla..." }, { "title": "SMS Pharmaceuticals Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/sms-pharmaceuticals-ltd-is-rated-hold-by-marketsmojo-4007904", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SMSPharmaceutic_mojoScore_4007904.png", "date": "2026-05-23 10:10:18", "description": "SMS Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 01 Sep 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 23 May 2026, providing investors with an up-to-date view of its performance and outlook." }, { "title": "SMS Pharmaceuticals Q4 FY26: Strong Profit Surge Masks Margin Concerns", "link": "https://www.marketsmojo.com/news/result-analysis/sms-pharmaceuticals-q4-fy26-strong-profit-surge-masks-margin-concerns-4007220", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SMSPharmaceutic_quaterlyResult_4007220.png", "date": "2026-05-22 19:31:28", "description": "SMS Pharmaceuticals Ltd., a Hyderabad-based active pharmaceutical ingredients manufacturer, delivered a robust 60.97% year-on-year growth in consolidated net profit for Q4 FY26, posting ₹32.71 crores compared to ₹20.32 crores in the corresponding quarter last year. However, the stellar profit performance was accompanied by concerning margin compression, with operating margins slipping to 16.77% from 20.74% in the previous quarter, raising questions about cost pressures and operational efficiency. The stock witnessed severe selling pressure following the results, plunging 10.54% to ₹381.20 on May 22, 2026, as investors reacted to the margin deterioration despite strong topline and bottomline growth." }, { "title": "SMS Pharmaceuticals Ltd Hits Intraday Low Amid Price Pressure on 22 May 2026", "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-ltd-hits-intraday-low-amid-price-pressure-on-22-may-2026-4005429", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SMSPharmaceutic_priceRelatedfactors_4005429.png", "date": "2026-05-22 14:00:51", "description": "SMS Pharmaceuticals Ltd experienced a notable intraday decline on 22 May 2026, with its share price falling sharply to an intraday low of Rs 387.4, marking a 9.08% drop from the previous close. This downturn occurred despite a broadly positive market environment, as the Sensex advanced by 0.61% during the session." }, { "title": "SMS Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-ltd-technical-momentum-shifts-signal-bullish-outlook-4000099", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SMSPharmaceutic_technicaldot_4000099.png", "date": "2026-05-20 08:01:55", "description": "SMS Pharmaceuticals Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators and an upgrade in its MarketsMOJO rating from Sell to Hold. The stock’s recent performance, combined with positive monthly and weekly signals, suggests growing investor confidence in this small-cap pharmaceutical player." }, { "title": "SMS Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3997924", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SMSPharmaceutic_technicaldot_3997924.png", "date": "2026-05-19 08:02:51", "description": "SMS Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish trend as of May 2026. Despite a slight dip in daily price, key technical indicators present a mixed picture, reflecting both resilience and caution for investors navigating this small-cap pharmaceutical player." } ], "total": 762, "sid": "517655", "stock_news_url": "https://www.marketsmojo.com/news/sms-pharmaceuticals-517655" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release", "datetime": "23-May-2026", "details": "Press Release on Financial Results for the year ended 31.03.2026", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation", "datetime": "23-May-2026", "details": "Investor Presentation", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Change in Registered Office Address", "datetime": "22-May-2026", "details": "Please find the enclosure", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "SMS Pharmaceuticals Ltd has declared <strong>40%</strong> dividend, ex-date: 22 Sep 25", "dt": "2025-09-22", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "SMS Pharmaceuticals Ltd has announced <strong>1:10</strong> stock split, ex-date: 17 Dec 15", "dt": "2015-12-17", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

18 May: Stock opens at Rs.397.65, down 0.64% amid cautious sentiment

19 May: Technical momentum shifts to mildly bullish; price rises 3.06% to Rs.409.80

20 May: Bullish technical signals strengthen; stock gains 3.43% to Rs.423.85

22 May: Sharp intraday reversal; stock closes down 10.54% at Rs.381.20

Week Open

Rs.397.65

Read full news article

SMS Pharmaceuticals Ltd is Rated Hold by MarketsMOJO

2026-05-23 10:10:18

SMS Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 01 Sep 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 23 May 2026, providing investors with an up-to-date view of its performance and outlook.

Read full news article

SMS Pharmaceuticals Q4 FY26: Strong Profit Surge Masks Margin Concerns

2026-05-22 19:31:28

SMS Pharmaceuticals Ltd., a Hyderabad-based active pharmaceutical ingredients manufacturer, delivered a robust 60.97% year-on-year growth in consolidated net profit for Q4 FY26, posting ₹32.71 crores compared to ₹20.32 crores in the corresponding quarter last year. However, the stellar profit performance was accompanied by concerning margin compression, with operating margins slipping to 16.77% from 20.74% in the previous quarter, raising questions about cost pressures and operational efficiency. The stock witnessed severe selling pressure following the results, plunging 10.54% to ₹381.20 on May 22, 2026, as investors reacted to the margin deterioration despite strong topline and bottomline growth.

Read full news article

SMS Pharmaceuticals Ltd Hits Intraday Low Amid Price Pressure on 22 May 2026

2026-05-22 14:00:51

SMS Pharmaceuticals Ltd experienced a notable intraday decline on 22 May 2026, with its share price falling sharply to an intraday low of Rs 387.4, marking a 9.08% drop from the previous close. This downturn occurred despite a broadly positive market environment, as the Sensex advanced by 0.61% during the session.

Read full news article

SMS Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-05-20 08:01:55

SMS Pharmaceuticals Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators and an upgrade in its MarketsMOJO rating from Sell to Hold. The stock’s recent performance, combined with positive monthly and weekly signals, suggests growing investor confidence in this small-cap pharmaceutical player.

Read full news article

SMS Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-05-19 08:02:51

SMS Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish trend as of May 2026. Despite a slight dip in daily price, key technical indicators present a mixed picture, reflecting both resilience and caution for investors navigating this small-cap pharmaceutical player.

Read full news article